Q43 pT3
3. Q43 pS13 4. Q43 pS16 5. Q43 pS13/pS16 6. Q43 S13D 7. Q43 S16D 8. Q43 S13D/S16D 9. Q43 Ack6 10. Q43 Ack9 11. Q43 T3D 12. Q43 pT3/Ack6 13. Q43 Ack6
Q43 Ack9
Images reported in the left part of figure 9 A including lanes 1, 3, 4, 5, 6, 7, and 8; samples in lanes 2, 9, 10, 11, 12, 13, and 14 are irrelevant for the manuscript and not cited anywhere.
Supplementary figure S5
Full-length blot image used for the right part of figure 9 A. Western blot of semisynthetic HTT exon 1 Q22 proteins (100 ng/lane; Q43 and Q22) used in this study (detection with mAb 4C9).
Lane legend:
5. Q22 pS16 6. Q22 pS13/pS16 7. Q22 S13D 8. Q22 S16D 9. Q22 S13D/S16D 10. Q23 Ack6 11. Q23 Ack9
Q23 Ack15
Images reported in the right part of figure 9 A including lanes 1, 4, 5, 6, 7, 8 and 9; samples in lanes 2, 3, 10, 11 and 12 are irrelevant for the manuscript and not cited anywhere.
Supplementary figure S6
Fluorescence signals obtained from the 2B7/MW1 (upper two graphs) and the 2B7/4C9 (lower two graphs) TR-FRET analysis of control and HD post-mortem human brains (cortex), performed at room temperature (two graphs on the right) and 4°C (two graphs on the left).
Three samples from control subjects and ten samples from HD subjects were analyzed in three dilution points starting from 12 µg of homogenates total protein. In order to perform the conformational immunoassays, the obtained signal point series were fitted with straight lines and the Y0 intercept value, of each line at each of the two tested temperature, was used to perform the ratio reported in figure 8 B, C and D, which is the readout value of the conformational immunoassay. 
